Effectiveness of palivizumab immunoprophylaxis to prevent respiratory syncytial virus hospitalizations in healthy full-term <6-month-old infants from the circumpolar region of Nunavik, Quebec, Canada
| Autor: | François D. Boucher, Rodica Gilca, Joseline G. Zafack, Marie Rochette, Jesse Papenburg, Hugues Charest, Marie-Noëlle Billard, Gaston De Serres |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Palivizumab
Pediatrics medicine.medical_specialty Circumpolar region Epidemiology business.industry lcsh:R Public Health Environmental and Occupational Health lcsh:Medicine Regular Article 030209 endocrinology & metabolism Circumpolar star Respiratory syncytial virus Healthy full-term infants Virus 03 medical and health sciences 0302 clinical medicine medicine 030212 general & internal medicine Respiratory hospitalization Respiratory system business Full Term medicine.drug |
| Zdroj: | Preventive Medicine Reports, Vol 20, Iss, Pp 101180-(2020) Preventive Medicine Reports |
| ISSN: | 2211-3355 |
| Popis: | In Quebec, Canada, eligibility for palivizumab (PVZ) immunoprophylaxis was expanded in fall 2016 to include healthy-full-term (HFT) infants residing in the circumpolar region of Nunavik and aged |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|